Nidda Healthcare GmbH
Takeover Offer of Bain Capital and Cinven for STADA successful
DGAP-News: Nidda Healthcare Holding AG / Key word(s): Offer
Dwight Poler and Michael Siefke, Managing Directors at Bain Capital, said: “We are pleased that the required majority of STADA’s shareholders has decided to accept our very attractive second Takeover Offer. This confirms that the decision to relaunch the offer was in the best interest of the Company and its shareholders. We thank the STADA Management and Supervisory Boards as well as the Advisory Board for their strong level of support, which has been instrumental in reaching this goal.” Supraj Rajagopalan and Bruno Schick, Partners at Cinven, said: “Following the successful closing of the transaction, we look forward to strengthening further STADA’s existing operations as well as growing the Company’s position as a global pharmaceutical business. Bain Capital and Cinven are committed to adding significant value to STADA including investment in organic growth and expansion through acquisitions. Building on STADA’s highly qualified employees, strong brands and market opportunities, we look forward to initiating the next phase of the Company’s development.” Pursuant to section 16 of the German Securities Acquisition and Takeover Act (Wertpapiererwerbs- und Übernahmegesetz), shareholders who have not yet tendered their shares can accept the Offer during the two weeks mandatory additional acceptance period, which starts with the publication of the final results pursuant to section 23 para 1. sentence 1 no. 2 the German Securities Acquisition and Takeover Act (Wertpapiererwerbs- und Übernahmegesetz). The offer document and all other information about the second Takeover Offer are available on the following website: www.niddahealthcare-angebot.de Media contacts: For Bain Capital Hazel Stevenson T +44 (0) 20 375 74 989 M +44 (0) 798 600 97 20 E hazel.stevenson@camarco.co.uk Ed Gascoigne-Pees T +44 (0) 20 375 74 984 M +44 (0) 788 400 19 49 E ed.gascoigne-pees@camarco.co.uk For Cinven Vanessa Maydon T +44 (0) 20 766 13325 M +44 (0) 7802 961 902 E vanessa.maydon@cinven.com Lutz Golsch T +49 69 92037 110 M +49 173 651 7710 E lutz.golsch@fticonsulting.com About Bain Capital Private Equity: Bain Capital Private Equity has partnered closely with management teams to provide the strategic resources that build great companies and help them thrive since its founding in 1984. Bain Capital’s global team of approximately 220 investment professionals creates value for its portfolio companies through its global platform and depth of expertise in key vertical industries including healthcare, consumer/retail, financial and business services, industrials, and technology, media and telecommunications. Bain Capital has offices in Boston, Chicago, New York, Palo Alto, San Francisco, Dublin, London, Luxembourg, Munich, Melbourne, Mumbai, Hong Kong, Shanghai, Sydney and Tokyo and has made investments in more than 300 companies to date. In addition to private equity, Bain Capital invests across asset classes including credit, public equity and venture capital, managing approximately USD 75 billion in total and leveraging the firm’s shared platform to capture opportunities in strategic areas of focus. For more information, visit www.baincapitalprivateequity.com About Cinven: Cinven is a leading international private equity firm focused on building world-class European and global companies. Its funds invest in six key sectors: Healthcare, Business Services, Consumer, Financial Services, Industrials, and Technology, Media and Telecommunications (TMT). Cinven has offices in key locations including: Frankfurt, London, Paris, Milan, Madrid, Hong Kong, and New York. Since 1988, Cinven funds have invested in 120 companies worth around EUR90 billion. Today Cinven has more than EUR15 billion in assets under management. Cinven takes a responsible strategic approach towards its portfolio companies, their employees, suppliers, local communities, the environment and society. For more information, please visit www.cinven.com Important Notice This announcement is neither an offer to purchase nor a solicitation of an offer to sell shares of the Company. The definite terms and conditions of the Takeover Offer, as well as further provisions concerning the Takeover Offer, have been published in the offer document following approval by the German Federal Financial Supervisory Authority. Investors and holders of shares in the Company are strongly advised to read the offer document and all other relevant documents regarding the Takeover Offer, since they contain important information. The Takeover Offer has been issued exclusively under the laws of the Federal Republic of Germany and certain applicable provisions of U.S. securities law. Any contract that is concluded on the basis of the Takeover Offer is exclusively governed by the laws of the Federal Republic of Germany and is to be interpreted in accordance with such laws.
18.08.2017 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG. |
Latest News
Latest Reports
No Reports found
Upcoming Events
No Events found
Webcasts
No Webcasts found